Marburg virus disease: Ethiopia has reported that its first outbreak is over. As reported, the outbreak caused 14 confirmed cases, 9 deaths and 5 recoveries. It was declared over after 42 days with no new confirmed case, according to reports dated 3 October 2026.
This guide explains what Marburg virus disease is, how it spreads, and what the 42-day rule really means. It also covers marburg virus disease symptoms, diagnosis, treatment, prevention and the history of every major marburg virus disease outbreak Africa has faced.
You will also find a clear note that this event is not the Ebola outbreak in the Democratic Republic of the Congo (DRC). The two are caused by different viruses in different countries.
Marburg virus disease is rare, but it is serious. The illness can cause severe fever, vomiting and bleeding, and many people who catch it do not survive. There is no licensed vaccine and no approved antiviral yet. Early supportive care improves the chances of survival.
We also look at the marburg virus disease market, meaning the vaccines, medicines and tests that are in development. We explain it without hype.
Every figure is attributed to its source and dated. Where a number comes from a secondary report and not yet from the World Health Organization (WHO), we say so. This article is for education only. It is not medical advice.
What Is Marburg virus disease?
Marburg virus disease is a severe illness caused by the Marburg virus. It belongs to the filovirus family, the same family as Ebola. The WHO describes it as a severe haemorrhagic fever with a high fatality rate.
The disease is rare. Outbreaks are small and sudden. Most happen in sub-Saharan Africa.
The virus was first identified in 1967. Laboratory workers in Marburg and Frankfurt in Germany, and in Belgrade, then in Yugoslavia, fell ill. They had handled tissues from imported African green monkeys. That is how the disease got its name.
On average, about half of the people who develop Marburg virus disease die. In past outbreaks, the fatality rate has ranged from roughly 24% to 88%. The rate depends on the virus strain and, above all, on how quickly good care is available.
Here is a quick summary:
- Cause: Marburg virus (a filovirus)
- Natural host: Rousettus fruit bats
- Incubation: 2 to 21 days
- Treatment: Supportive care; no licensed antiviral
- Vaccine: None licensed yet
Because Marburg virus disease is a YMYL (Your Money or Your Life) topic, we rely on WHO, CDC and national health agency information throughout.
Ethiopia’s Outbreak: What Was Reported
Ethiopia’s first-ever Marburg virus disease outbreak has now been reported as over. This is good news. It is also a story that is easy to misread, so we keep to the facts.
The numbers, as reported
As reported, the outbreak involved:
- 14 confirmed cases
- 9 deaths
- 5 recoveries
Those three figures add up. Fourteen people were confirmed to be infected. Nine died and five recovered.
These figures come from news reports dated 3 October 2026 that cite the government process. At the time of writing, we have not seen a dedicated WHO news release announcing the end of the outbreak. The numbers should be checked against official WHO and Ethiopian Ministry of Health updates before you rely on them.
A short timeline
- 14 November 2025: The outbreak was confirmed in South Ethiopia.
- Following months: Contact tracing, isolation of patients and enhanced surveillance continued.
- Early October 2026: Ethiopia was reported to have declared the outbreak over after 42 days with no new confirmed case.
Health workers were infected
The reports say three health workers were infected during the outbreak. This is a pattern seen in many marburg virus disease outbreak Africa events. Health workers are at risk when protective equipment or infection control is missing, especially before the disease is recognised.
The lesson is simple. Infection prevention and control (IPC) in clinics protects staff, patients and the wider community.
Is it still an active outbreak?
No. Ethiopia is not framed as an active outbreak. The reported declaration means the country has completed the required monitoring period. Authorities will still keep surveillance running, because the virus can return from animal sources.
The 42-Day Rule, Explained Simply
You may see the phrase “42-day criterion” in the news. It is the standard used to declare an outbreak of Marburg virus disease over.
Here is how it works in plain language.
- Health teams count from the day the last confirmed patient tests negative twice, or is safely buried.
- They then wait 42 days.
- If no new confirmed case appears in that time, the outbreak can be declared over.
Why 42 days?
The incubation period is up to 21 days. The 42-day period is double that maximum. Waiting two full incubation cycles gives a safety margin. It makes sure that any hidden chain of infection would have shown itself.
What the end declaration does not mean
It does not mean the virus is gone from nature. Bats can still carry the virus. It does not mean the risk is zero. It means the person-to-person chain of transmission in that outbreak has been broken.
After the declaration, countries usually keep up a period of heightened surveillance. This helps catch any late flare-up or new spillover from animals.
This Is Not the DRC Ebola Event
Many readers have confused two separate news stories. Let us be clear.
Ethiopia’s Marburg virus disease event is not the DRC Ebola event.
Here are the main differences:
- Different virus: Marburg virus versus Ebola virus. In the DRC, the outbreak reported by WHO involves the Bundibugyo strain of Ebola.
- Different country: Ethiopia versus the Democratic Republic of the Congo.
- Different status: Ethiopia’s outbreak was reported as over. The DRC situation has been the subject of ongoing WHO updates.
- Different vaccine picture: There is no licensed vaccine for Marburg. There is also no licensed vaccine for the Bundibugyo strain of Ebola.
The two viruses are cousins. Both are filoviruses, and both can cause haemorrhagic fever. That is why the headlines blur together. Still, they are separate diseases with separate outbreaks.
If you want updates on the Ebola event, follow WHO Disease Outbreak News and your national health agency. This article focuses only on Marburg.
What Causes Marburg virus disease?
The cause is the Marburg virus. Researchers also recognise a closely related virus, Ravn virus. Both can cause the same illness.
The role of bats
The natural host is the Egyptian rousette fruit bat, Rousettus aegyptiacus. These bats can carry the virus without being visibly sick.
Outbreaks often begin when people spend long periods in caves or mines where these bats live. Miners and cave visitors have been among the first patients in past outbreaks.
Spillover to humans
A single spillover event can start an outbreak. A person is infected by contact with bat fluids or infected animal material. After that, the virus can spread from person to person.
How Marburg virus disease Spreads
Understanding transmission is the best way to stay safe. The CDC explains how the virus spreads between people in clear terms.
Person-to-person spread
The virus spreads through direct contact with:
- Blood
- Saliva, vomit, urine, stool and other body fluids
- Semen and breast milk
- Contaminated needles, bedding and clothing
The contact usually needs to involve broken skin or the eyes, nose or mouth.
Who is most at risk?
- Family members caring for a sick relative at home
- Health workers without proper protective equipment
- People who prepare or touch the bodies of those who have died
- Visitors to bat caves or mines in affected regions
Bodies remain infectious
People who die from it are still highly infectious. Traditional burial practices that involve touching the body have fuelled spread in past outbreaks. Safe and dignified burials, carried out by trained teams, are a key part of the response.
How it does not spread
It does not spread through casual contact. It does not spread through the air like measles or flu. A person is not contagious before symptoms start.
Marburg Virus Disease Symptoms
The marburg virus disease symptoms begin suddenly. Early signs look like many common illnesses, such as malaria or typhoid. That makes early recognition hard.
Early symptoms (days 1 to 3)
- High fever
- Severe headache
- Intense muscle aches
- General weakness and malaise
- Chills
Middle phase (days 3 to 7)
- Watery diarrhoea
- Stomach pain and cramping
- Nausea and vomiting
- Dry throat and chest pain
- A non-itchy rash on some patients
Patients may look very ill, with sunken eyes and an expressionless face. This is sometimes described as a “ghost-like” appearance.
Severe phase (day 5 onward)
- Bleeding from the gums, nose or injection sites
- Blood in vomit or stool
- Confusion, agitation or irritability
- Shock and organ failure
Death, when it happens, typically occurs 8 to 9 days after symptoms begin. It is usually linked to severe fluid loss, blood loss and shock.
Not everyone bleeds heavily
Some patients do not show dramatic bleeding. The name “haemorrhagic fever” can mislead. Fluid loss and organ failure are major dangers, too.
Red-flag combination
A fever plus any of these should prompt urgent medical advice:
- Recent contact with a person who has Marburg virus disease
- Recent visit to a cave or mine in an affected region
- Care for a sick person with unexplained bleeding
- Travel to an area with an active outbreak in the past 21 days
Incubation Period
The incubation period is the time from infection to the first symptoms. For this disease, it is 2 to 21 days.
This matters for three reasons:
- Monitoring: Contacts of a patient are watched for 21 days.
- Travel: Anyone returning from an outbreak area is advised to monitor their health for 21 days.
- End of outbreak: The 42-day rule is built on twice this period.
A person is not infectious during the incubation period. They become infectious once symptoms appear. The risk rises as the illness gets worse.
How Is Marburg virus disease Diagnosed?
Diagnosis is difficult in the early stage. The first symptoms look like malaria, typhoid fever, cholera, meningitis or Lassa fever. It can also be confused with Ebola.
Laboratory tests
Doctors confirm the disease only with laboratory testing. Common tests include:
- RT-PCR: Detects the virus’s genetic material in blood
- Antigen-detection tests: Look for viral proteins
- ELISA: Detects antibodies or antigens
- Virus isolation: Done only in high-security laboratories
Samples are highly dangerous. They must be handled by trained staff in proper biosafety conditions.
Why fast testing matters
A quick, accurate diagnosis lets teams isolate the patient and trace contacts. Every day of delay gives the virus more chances to spread.
Treatment and Care
There is no licensed antiviral drug for this illness. The WHO and other health bodies recommend early supportive care. Good supportive care improves survival.
Supportive care includes
- Oral or intravenous rehydration
- Oxygen therapy when needed
- Blood pressure support
- Treatment of other infections
- Replacing lost blood or clotting factors where possible
- Pain and nausea control
Experimental treatments
Several experimental medicines have been studied or used under special protocols. These include the antiviral remdesivir and monoclonal antibody candidates. They are not yet approved for general use.
Patients should receive them only through approved trials or emergency protocols. Never seek unproven remedies. There are no “miracle cures” for Marburg virus disease.
Care of survivors
Survivors may have long recovery periods. Reported after-effects include joint and muscle pain, fatigue and eye inflammation. The virus can persist in some body sites, such as semen, for a time. Survivors are therefore given guidance and follow-up.
Prevention
You can lower the risk of Marburg virus disease with practical steps.
In communities
- Avoid entering caves or mines with large bat colonies in affected areas.
- Avoid contact with bats and with monkeys or other wild animals that look sick or are found dead.
- Do not touch the body of a person who died from a suspected case.
- Wash hands often with soap and water.
- Report unexplained fever with bleeding to a health centre right away.
For caregivers at home
- Do not care for a suspected patient without protective gear and guidance.
- Call a health facility so trained staff can take over.
- Keep bedding and clothing away from others until staff arrive.
In health facilities
- Use gloves, gowns, masks and eye protection.
- Isolate suspected patients straight away.
- Dispose of sharps and waste safely.
- Disinfect surfaces with approved products.
For travellers
- Check official travel advice before travelling to an area with an active outbreak.
- Avoid contact with sick people, bats and bushmeat.
- Monitor your health for 21 days after returning.
- If you get a fever, call a health service first. Tell them where you travelled.
Vaccines
At the time of writing, no vaccine is licensed for it. Some candidates have been tested in trials during recent outbreaks. Please see our market section below.
The Public Health Response
An outbreak response is a team effort. When a case is confirmed, health authorities usually act on several fronts at once.
- Surveillance: Finding and confirming cases quickly
- Contact tracing: Listing and monitoring everyone who met a patient, for 21 days
- Case management: Isolating patients and giving supportive care
- Infection control: Protecting health workers and clinics
- Safe burials: Training teams to handle bodies safely
- Community engagement: Explaining risks and addressing rumours
- Laboratory capacity: Testing samples quickly
- Research: Trials of vaccines and treatments where appropriate
The WHO offers a wide overview of the disease and response work for countries and partners. National ministries of health lead the response on the ground.
What Ethiopia’s outbreak shows
Ethiopia’s reported ending shows that rapid detection and strict follow-up can stop a chain of transmission. It also shows the value of protecting health workers. Three infections among staff, as reported, are a reminder of how important IPC is.
Marburg Virus Disease Outbreak Africa: A Short History
Most known outbreaks have occurred in Africa. The CDC keeps a list of past outbreaks of the disease in Africa and beyond. The figures below are approximate and drawn from WHO and CDC summaries. Please verify them against the latest official fact sheet before you publish or cite them.
- 1967, Germany and Serbia: The first outbreak, linked to laboratory monkeys. Around 31 cases and 7 deaths. These were outside Africa.
- 1998 to 2000, DRC: A long outbreak linked to mining activity. About 154 cases and 128 deaths.
- 2004 to 2005, Angola: The largest outbreak recorded so far. About 374 cases and 329 deaths.
- 2017, Uganda: A small outbreak, with 3 cases and 3 deaths.
- 2021, Guinea: A single case, the first in West Africa.
- 2022, Ghana: Three cases and three deaths, among the first in Ghana.
- 2023, Equatorial Guinea: Confirmed and probable cases, with a significant number of deaths.
- 2024, Rwanda: About 66 cases and 15 deaths. The lower fatality rate was linked to rapid hospital care, and experimental products were used under protocol.
- 2025, Tanzania: A small outbreak with a high proportion of deaths.
- 2025 to 2026, Ethiopia: The country’s first outbreak, with 14 confirmed cases, 9 deaths and 5 recoveries, as reported. Reported as over in early October 2026.
What the history tells us
- Outbreaks have grown more frequent in recent years, and have reached new countries.
- Fast detection and good care appear to reduce deaths. Rwanda’s experience is often cited for this.
- Each new country brings a new set of challenges, from limited labs to community fears.
Researchers continue to study why more countries are now reporting cases. Better detection may be part of the answer. Bat habitats and human activity may also play a role.
The Marburg Virus Disease Market: Vaccines, Drugs and Tests
When people search for the marburg virus disease market, they usually mean one of two things. They may mean the commercial market for vaccines, treatments and diagnostics. Or they may mean the research pipeline behind them.
We do not quote market-size figures here. Third-party market reports vary widely and are often not verified. Using unverified numbers on a YMYL topic would not be responsible.
What we can describe is the landscape.
Why the commercial market is small
- Outbreaks are rare and unpredictable.
- Case numbers are low, so there are few paying patients.
- Most affected countries have limited health budgets.
- Development is therefore driven mainly by public funders, governments, global health agencies and non-profit groups, not by usual commercial demand.
Vaccines in development
No vaccine is licensed. Several candidates have been in development or early trials. These include adenovirus-based and other viral-vector vaccines. Some have been offered in outbreak settings under trial protocols.
Their effectiveness is still being studied. Until a vaccine is licensed, it is not a replacement for the basic control measures.
Treatments in development
Candidates include antivirals and monoclonal antibodies. Trials are small because outbreaks are small. This makes it hard to collect strong evidence.
Diagnostics
Rapid, reliable tests are essential. PCR tests are accurate but need labs. Work continues on faster tests that can be used near the patient, in rural clinics.
What to watch
- Whether a vaccine moves toward formal licensing
- Funding from global health partners
- Larger trials during future outbreaks
- Regional manufacturing and stockpile plans
For readers who track the marburg virus disease market as investors or analysts: treat any single market-size figure with caution. Check the method, the date and who paid for the report.
Is Marburg virus disease a Risk Outside Africa?
The risk to the general public outside affected areas is low. Cases abroad have almost always been linked to travel or to health care contact.
Aeroplane passengers are not at risk from casual contact. The virus is not airborne. Reported spread has been through contact with the body fluids of a sick person.
Health systems in most countries have plans to isolate and test suspected cases. If you plan to travel to an affected area, follow official advice.
When to See a Doctor
Seek urgent medical advice if both of these apply:
- You have a sudden fever, severe headache, muscle pain, vomiting or diarrhoea, and
- In the past 21 days you had contact with a suspected or confirmed case, visited a cave or mine in an affected area, or travelled to an area with an active outbreak.
What to do
- Call your local health service or emergency line first. Do not walk into a busy clinic without warning.
- Tell them your symptoms and your travel or contact history.
- Avoid public transport and close contact with others.
- Do not self-medicate with unproven remedies.
Seek emergency care right away if you have bleeding that does not stop, confusion, trouble breathing or fainting.
Most people with fever have common illnesses such as malaria, flu or a stomach bug. Still, it is always safest to mention a risk factor early.
Frequently Asked Questions
What is Marburg virus disease?
Marburg virus disease is a rare, severe viral illness caused by the Marburg virus. It causes fever, vomiting and, in many patients, bleeding. It belongs to the same virus family as Ebola.
How many cases were reported in Ethiopia’s outbreak?
As reported, there were 14 confirmed cases, 9 deaths and 5 recoveries. These figures come from reports dated 3 October 2026. Please check them against WHO and Ethiopian Ministry of Health updates.
What does the 42-day criterion mean?
It means 42 days must pass with no new confirmed case after the last patient tests negative twice or is buried. That is twice the 21-day maximum incubation period. After this, an outbreak can be declared over.
Is Ethiopia’s outbreak the same as the DRC Ebola outbreak?
No. They are different diseases caused by different viruses in different countries. Marburg and Ebola are related, but this event is not the DRC Ebola event.
What are the main marburg virus disease symptoms?
The main signs are sudden high fever, severe headache and muscle aches. Later come vomiting, diarrhoea and, in some patients, bleeding. See a doctor quickly if you have these signs after contact with a suspected case.
Is there a cure or vaccine?
No licensed antiviral or vaccine exists yet. Early supportive care, such as fluids and oxygen, improves survival. Experimental products are available only in trials or special protocols.
Where can I read the official WHO marburg virus disease fact sheet?
The WHO publishes a regularly updated fact sheet on its website. Searches for the who marburg virus disease factsheet and the who marburg virus disease fact sheet lead to the same page. It is the best starting point for reliable facts.
Can the disease spread through the air?
No. The virus spreads through direct contact with body fluids and contaminated objects. It is not known to spread through the air.
Key Takeaways
- Marburg virus disease is rare but serious, and it is caused by a filovirus.
- Ethiopia’s first outbreak was reported over in early October 2026, with 14 confirmed cases, 9 deaths and 5 recoveries, as reported.
- The 42-day rule is twice the maximum incubation period.
- This is not the DRC Ebola event.
- There is no licensed vaccine or antiviral. Early supportive care helps.
- Prevention relies on safe burials, infection control and avoiding bat caves in affected regions.
Data Notes and Sources
- Ethiopia figures and the end-of-outbreak report: news reports dated 3 October 2026, citing the government process. A dedicated WHO news release had not been confirmed at the time of writing.
- Disease facts: WHO fact sheet, CDC Marburg pages.
- Outbreak history figures are approximate. Verify against current WHO and CDC pages.
- Information current as of 5 October 2026.
Medical Disclaimer
This article is for general information only. It does not replace advice from a qualified doctor or health professional. Do not use it to diagnose or treat any illness. If you think you have been exposed to Marburg virus disease, or you feel unwell, contact your local health service immediately. Information may change as outbreaks evolve.
